Your Experienced Infectious Disease and Vaccines Partner

From conducting clinical trials to meeting post-approval regulatory requirements, we can help guide your product on its critical path to rapid approval and beyond.

Our Expertise
UBC’s recent global vaccine and infectious disease experience includes 42 projects encompassing clinical trials, observational studies, registries and safety surveillance.

Most notably, we quickly accelerated a study to collect information about the potential effects of a vaccine on developing fetuses during the H1N1 pandemic. 

Our experts have authored and supported countless submissions to regulatory authorities on safety, efficacy and value, and remain current on the latest global regulatory trends and changes.

Read our experience summary to learn more about our vaccine and infectious disease experience and contact us to discuss how we can support your business continuity during this critical time.

Let's Discuss

Meet with our vaccines and infectious disease experts to learn how our vast experience across all therapy areas can help you prove your products' efficacy, safety and value.

Our Infectious Disease Experts
Together, our scientific leadership team have authored and supported countless submissions to regulatory authorities on safety, efficacy and value, and remain current on the latest global regulatory trends and changes.

Annette Stemhagen, DrPH, FISPE
Senior Vice President & Chief Scientific Officer

Bruce Smith, PharmD
Executive Director, Scientific & Operational Strategy

Patricia Mosher
Vice President, Global Late Stage Operations & Strategic Engagement
Full-Service Clinical Development Solutions
UBC harnesses four decades of global experience in strategic clinical development and execution of full-service studies (Phase II - IV) across vast therapeutic areas, including rare disease and cell & gene therapy. Our deeply committed team engages with our clients to provide strategic support and evidence-generated approaches to meet your most critical needs surrounding product safetyeffectiveness and value.